Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Sade Group
Sade Group Overview
Sade Biotech developed ASAYA, a platform for optimization of clinical outcomes by managing medical cannabis treatment with big data analysis and algorithms based on experts’ best practices.
ASAYA integrates real-world practice and patients reported outcomes, with human and machine intelligence, to provide practical guidance for the use of medical cannabis. Facilitated by cutting edge technology – machine learning, IoT, mobile applications and predictive analytics – ASAYA promotes to better medical cannabis care. Ultimately, the whole medical cannabis ecosystem will benefit – HCPs, patients, growers & researchers.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Sade Group Climate Tech relevance
undefined
Latest News
No Data, yet.
Sorry, no content found under this section.
Jul 7, 2019
en.globes.co.il
Ori Yehudai quits cannabis co Sade after two months
#Management Changes
May 16, 2019
www.prnewswire.com
After $7.1 Billion Sale Of Frutarom, Ori Yehudai To Join The Sade Group As Active Chairman and Investor